Correlations between Income Inequality and Antimicrobial Resistance
Open Access
- 29 August 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (8) , e73115
Abstract
The aim of this study is to investigate if correlations exist between income inequality and antimicrobial resistance. This study’s hypothesis is that income inequality at the national level is positively correlated with antimicrobial resistance within developed countries. Income inequality data were obtained from the Standardized World Income Inequality Database. Antimicrobial resistance data were obtained from the European antimicrobial Resistance Surveillance Network and outpatient antimicrobial consumption data, measured by Defined daily Doses per 1000 inhabitants per day, from the European Surveillance of antimicrobial Consumption group. Spearman’s correlation coefficient (r) defined strengths of correlations of: > 0.8 as strong, > 0.5 as moderate and > 0.2 as weak. Confidence intervals and p values were defined for all r values. Correlations were calculated for the time period 2003-10, for 15 European countries. Income inequality and antimicrobial resistance correlations which were moderate or strong, with 95% confidence intervals > 0, included the following. Enterococcus faecalis resistance to aminopenicillins, vancomycin and high level gentamicin was moderately associated with income inequality (r= ≥0.54 for all three antimicrobials). Escherichia coli resistance to aminoglycosides, aminopenicillins, third generation cephalosporins and fluoroquinolones was moderately-strongly associated with income inequality (r= ≥0.7 for all four antimicrobials). Klebsiella pneumoniae resistance to third generation cephalosporins, aminoglycosides and fluoroquinolones was moderately associated with income inequality (r= ≥0.5 for all three antimicrobials). Staphylococcus aureus methicillin resistance and income inequality were strongly associated (r=0.87). As income inequality increases in European countries so do the rates of antimicrobial resistance for bacteria including E. faecalis, E. coli, K. pneumoniae and S. aureus. Further studies are needed to confirm these findings outside Europe and investigate the processes that could causally link income inequality and antimicrobial resistance.Keywords
This publication has 34 references indexed in Scilit:
- European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in EuropeJournal of Antimicrobial Chemotherapy, 2011
- European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997–2009)Journal of Antimicrobial Chemotherapy, 2011
- Optimizing dosage to prevent emergence of resistance – lessons from in vitro modelsCurrent Opinion in Pharmacology, 2011
- Influence of patient payment on antibiotic prescribing in Irish general practice: a cohort studyBritish Journal of General Practice, 2011
- European Surveillance of Antimicrobial Consumption (ESAC): systemic antiviral use in EuropeJournal of Antimicrobial Chemotherapy, 2011
- Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging EpidemicClinical Microbiology Reviews, 2010
- Role of Antimicrobial Selective Pressure and Secondary Factors on Antimicrobial Resistance Prevalence inEscherichia colifrom Food-Producing Animals in JapanJournal of Biomedicine and Biotechnology, 2010
- Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countriesBMJ, 2009
- Socioeconomic determinants of regional differences in outpatient antibiotic consumption: Evidence from SwitzerlandHealth Policy, 2006
- Social Inequalities and Emerging Infectious DiseasesEmerging Infectious Diseases, 1996